Skip to main content

Memantine (International)

In the US, Memantine (memantine systemic) is a member of the drug class miscellaneous central nervous system agents and is used to treat Alzheimer's Disease, Autism and Migraine.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06DX01

CAS registry number (Chemical Abstracts Service)

0019982-08-2

Chemical Formula

C12-H21-N

Molecular Weight

179

Therapeutic Categories

Treatment of Alzheimer's disease

N-methyl-D-aspartate (NMDA) receptor antagonist

Chemical Name

Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimetyl-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs